Literature DB >> 3484749

Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome.

N K Maclaren, W J Riley.   

Abstract

The inherited susceptibility to autoimmune Addison's disease was found to be strongly associated with human leukocyte antigens (HLA)-DR3 and DR4 alleles. In a study of 45 white patients from the United States with the disease, the relative risks (the number of times that an individual is at risk for Addison's disease if they had a marker, compared to those without such marker) were found to be 6.0, 4.6, and 26.5 for the DR3 allele, the DR4 allele, and for DR3/DR4 heterozygotes, respectively. Frequencies of DR2, DR5, and DR7 in the patients with Addison's disease were significantly decreased in comparison to 265 individuals in the control population. These HLA-DR frequencies in patients with Addison's disease were similar to those for 723 patients with insulin-dependent diabetes (IDD). However, the above HLA-DR associations persisted even when only data from the 37 patients with Addison's disease who did not have IDD were considered. Adrenocortical autoantibodies in 23 patients with IDD who did not have Addison's disease were equally frequent among those with DR4 and DR3 alleles. In contrast, HLA-DR frequencies in 17 patients with type I autoimmune polyglandular syndrome (chronic mucocutaneous moniliasis, hypoparathyroidism, Addison's disease, etc.) were not different from control. We conclude that genetic susceptibility to autoimmune Addison's disease may involve the same HLA-associated genetic determinants as IDD, except when Addison's disease occurs as part of type I autoimmune polyglandular syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484749     DOI: 10.1210/jcem-62-3-455

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

Review 1.  Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders.

Authors:  Akane Ide; George S Eisenbarth
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Polymorphisms of DQ beta genes in HLA-DR4 haplotypes from healthy and diabetic individuals.

Authors:  V Henson; N Maclaren; W Riley; E K Wakeland
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 3.  Polyendocrine autoimmunity.

Authors:  Jennifer M Barker
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

4.  A real-time PCR approach for rapid high resolution subtyping of HLA-DRB1*04.

Authors:  Vivian H Gersuk; Gerald T Nepom
Journal:  J Immunol Methods       Date:  2006-10-02       Impact factor: 2.303

Review 5.  Genetics of autoimmune endocrine diseases.

Authors:  J F Bach; S Caillat-Zucman
Journal:  Springer Semin Immunopathol       Date:  1993

Review 6.  Autoimmune Addison's disease.

Authors:  A Muir; D A Schatz; N K Maclaren
Journal:  Springer Semin Immunopathol       Date:  1993

7.  Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I.

Authors:  L A Velloso; O Winqvist; J Gustafsson; O Kämpe; F A Karlsson
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

8.  Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.

Authors:  Y Fu; D M Nathan; F Li; X Li; D L Faustman
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 9.  Autoimmune polyglandular syndrome Type 2: the tip of an iceberg?

Authors:  C Betterle; F Lazzarotto; F Presotto
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

10.  Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease.

Authors:  O Winqvist; J Gustafsson; F Rorsman; F A Karlsson; O Kämpe
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.